Table 3.
Time point | Placebo | Lateral Branch Denervation (n=14) | Lateral Branch Denervation Crossover (n=11) |
---|---|---|---|
Baseline | (n=14) | ||
Mean (SD, range) | 47.9 (9.3, 28–59) | 37.1 (10.6, 18–49) | 43.6 (14, 16–70) |
Median (interquartile range) | 50.5 (44–56) | 41, (26–46) | 41 (34–56) |
One month | (n=14) | *, **, *** | |
Mean (SD, range) | 43.6 (14, 16–70) | 20.9 (10.9, 4–38) | 34.3 (16.2, 4–58) |
Median (interquartile range) | 41 (34–56) | 19 (14–29) | 33 (24–46) |
Three months | (n=2) | *** | *** |
Mean (SD, range) | 24 (8.5, 18–30) | 18.5 (11.6, 0–36) | 19.4 (18.1, 0–44) |
Median (interquartile range) | 24 (18–30) | 20 (9.5–27) | 16 (4–44) |
Six months | *** | *** | |
Mean (SD, range) | No data | 22.6 (10.6, 7–40) | 24.3 (21.0, 0–56) |
Median (interquartile range) | 20 (16–24) | 20 (8–42) |
P<0.05 as compared to placebo group
P<0.05 as compared to lateral branch denervation crossover group
P<0.05 as compared to baseline of the respective group